201 related articles for article (PubMed ID: 16305099)
1. [Comparative analysis of the efficacy and biocompatibility of various methods of dialysis].
Zivanović M; Hrvacević R; Kovacević Z; Veljancić L; Vujanić S
Vojnosanit Pregl; 2005 Oct; 62(10):725-9. PubMed ID: 16305099
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
[TBL] [Abstract][Full Text] [Related]
3. Postdialysis urea rebound: determinants and influence on dialysis delivery in chronic hemodialysis patients.
Leblanc M; Charbonneau R; Lalumière G; Cartier P; Déziel C
Am J Kidney Dis; 1996 Feb; 27(2):253-61. PubMed ID: 8659502
[TBL] [Abstract][Full Text] [Related]
4. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
McCarthy JT; Jenson BM; Squillace DP; Williams AW
Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
[TBL] [Abstract][Full Text] [Related]
5. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
7. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD.
McKane W; Chandna SM; Tattersall JE; Greenwood RN; Farrington K
Kidney Int; 2002 Jan; 61(1):256-65. PubMed ID: 11786108
[TBL] [Abstract][Full Text] [Related]
8. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
[TBL] [Abstract][Full Text] [Related]
9. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
Zehnder C; Gutzwiller JP; Renggli K
Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
[TBL] [Abstract][Full Text] [Related]
10. Is post-dialysis urea rebound significant with long slow hemodialysis?
Jean G; Chazot C; Charra B; Terrat JC; Vanel T; Calemard E; Laurent G
Blood Purif; 1998; 16(4):187-96. PubMed ID: 9736788
[TBL] [Abstract][Full Text] [Related]
11. The dose of hemodialysis and patient mortality.
Held PJ; Port FK; Wolfe RA; Stannard DC; Carroll CE; Daugirdas JT; Bloembergen WE; Greer JW; Hakim RM
Kidney Int; 1996 Aug; 50(2):550-6. PubMed ID: 8840285
[TBL] [Abstract][Full Text] [Related]
12. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
Szepietowski T; Krajewska M
Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
[TBL] [Abstract][Full Text] [Related]
13. Update on Postdialysis Rebound by a New Technology in Hemodialysis.
Testal AG; Marín DH; Maset RG; Maicas PR; Salvador ISR; Díaz PO; Najera JEF; De Juan ET; Carrera CB
Ther Apher Dial; 2017 Oct; 21(5):473-477. PubMed ID: 28795535
[TBL] [Abstract][Full Text] [Related]
14. Hemodialysis urea rebound and membrane biocompatibility: accuracy of Kt/V estimations.
Navarro JF; del Castillo N; Fernández JL; Macía ML; Méndez ML; Chahin J; García-Nieto V; Gallego E; Mora-Fernández C; García J
Artif Organs; 1997 Feb; 21(2):91-5. PubMed ID: 9028489
[TBL] [Abstract][Full Text] [Related]
15. Does treatment modality have an impact on anemia in patients with chronic renal failure? Effect of low- and high-flux biocompatible dialysis.
Opatrný K; Reischig T; Vienken J; Eiselt J; Vít L; Opatrná S; Sefrna F; Racek J; Brown GS
Artif Organs; 2002 Feb; 26(2):181-8. PubMed ID: 11879248
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Dialysis Modality and Membrane Performance on Native Immunity in Dialysis Patients.
Pappas EM; Mpournaka S; Katopodis P; Chardalias A; Tsakas S; Theodoros T; Evangelos E; Katopodis KP; Goumenos DS
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):25-32. PubMed ID: 31605588
[TBL] [Abstract][Full Text] [Related]
17. Clinical Performance Assessment of CorDiax Filters in Hemodialysis and Hemodiafiltration.
Potier J; Bowry S; Canaud B
Contrib Nephrol; 2017; 189():237-245. PubMed ID: 27951574
[TBL] [Abstract][Full Text] [Related]
18. [The evaluation of hemodialysis adequacy during the use of different dialysis membranes].
Stasević Z; Subarić-Gorgieva G; Krcmarević J; Stolić R; Trajković G
Srp Arh Celok Lek; 2007; 135(1-2):48-53. PubMed ID: 17503568
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of methods to calculate dialysis dose in daily hemodialysis].
Maduell F; Gutiérrez E; Navarro V; Torregrosa E; Martínez A; Rius A
Nefrologia; 2003; 23(4):344-9. PubMed ID: 14558334
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different methods for hemodialysis evaluation by means of ROC curves: from artificial intelligence to current methods.
Fernández EA; Valtuille R; Presedo JM; Willshaw P
Clin Nephrol; 2005 Sep; 64(3):205-13. PubMed ID: 16175945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
